2,3,4,6-tetrachlorophenol has been researched along with Aura in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 10 (90.91) | 2.80 |
| Authors | Studies |
|---|---|
| Pietrafusa, N; Specchio, N; Vigevano, F | 1 |
| Karkare, S; Kothare, SV; Shah, YD; Varughese, RT | 1 |
| Abou-Khalil, B; Aboumatar, S; Klein, P; Krauss, GL; Rosenfeld, WE; Sperling, MR | 1 |
| Ángel Calleja, M; Gil, A; Navarro, A; Serratosa, JM; Subías Labazuy, S; Toledo, M; Villanueva, V | 1 |
| Keam, SJ | 1 |
| Brigo, F; Del Giovane, C; Lattanzi, S; Silvestrini, M; Striano, P; Trinka, E; Zaccara, G | 1 |
| Steinhoff, BJ | 1 |
| Löscher, W; Sills, GJ; White, HS | 1 |
| Ferrari, L; Nisman, A; Rosenfeld, WE | 1 |
| Klein, P; Löscher, W | 1 |
| Ahrens, J; Buchholz, V; de la Roche, J; Dengler, R; Haeseler, G; Krampfl, K; Leuwer, M | 1 |
6 review(s) available for 2,3,4,6-tetrachlorophenol and Aura
| Article | Year |
|---|---|
Is Cenobamate the Breakthrough We Have Been Wishing for?
Topics: Anticonvulsants; Carbamates; Chlorophenols; Epilepsy; Humans; Seizures; Tetrazoles | 2021 |
Cenobamate: First Approval.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Approval; Epilepsies, Partial; Epilepsy; Humans; Tetrazoles | 2020 |
Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsy; Humans; Randomized Controlled Trials as Topic; Seizures; Tetrazoles; Treatment Outcome | 2020 |
[Cenobamate-a new perspective for epilepsy treatment].
Topics: Anticonvulsants; Carbamates; Chlorophenols; Epilepsy; Humans; Seizures; Tetrazoles | 2021 |
The ups and downs of alkyl-carbamates in epilepsy therapy: How does cenobamate differ?
Topics: Anticonvulsants; Carbamates; Chlorophenols; Epilepsy; Humans; Tetrazoles; Treatment Outcome | 2021 |
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
Topics: Animals; Anticonvulsants; Bromides; Carbamates; Chlorophenols; Drug Therapy, Combination; Epilepsy; Humans; Salts; Seizures; Tetrazoles; Treatment Outcome | 2021 |
1 trial(s) available for 2,3,4,6-tetrachlorophenol and Aura
| Article | Year |
|---|---|
Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Topics: Adult; Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Humans; Seizures; Tetrazoles; Treatment Outcome | 2021 |
4 other study(ies) available for 2,3,4,6-tetrachlorophenol and Aura
| Article | Year |
|---|---|
Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamates; Child; Chlorophenols; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Humans; Retrospective Studies; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Double-Blind Method; Drug Therapy, Combination; Epilepsy; Humans; Seizures; Tetrazoles; Treatment Outcome | 2022 |
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain.
Topics: Adult; Carbamates; Chlorophenols; Cost-Benefit Analysis; Epilepsy; Humans; Lacosamide; Quality-Adjusted Life Years; Spain; Tetrazoles | 2022 |
4-Chloropropofol enhances chloride currents in human hyperekplexic and artificial mutated glycine receptors.
Topics: Chlorine; Chlorophenols; Dose-Response Relationship, Drug; Epilepsy; Genetic Diseases, X-Linked; HEK293 Cells; Humans; Ion Channel Gating; Membrane Potentials; Mutagenesis, Site-Directed; Receptors, Glycine; Reflex, Abnormal; Xylenes | 2012 |